Price
Target price
€0.31
€0.31
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Thiogenesis Therapeutics Corp. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
News
Thiogenesis Appoints Dr. Gilad Aharon to its Board of Directors
SAN DIEGO, CA - June 17, 2026 - Thiogenesis Therapeutics, Corp. (TSXV: TTI; OTCQX: TTIPF) (“Thiogenesis” or the “Company”), a clinical-stage biotechnology company developing next-generation
